Insight journal - Company, Insight journal - Deals and alliances

Big pharma and big biotech companies deal analysis – 2007 to 2013

Posted on 07 August 2013

Tags: , , ,

Partnering trends and deal analysis reviewed with over 4,000 deals entered by the world’s leading fifty big pharma and big biotech companies.

This deal analysis article is an abstract from the reports: Partnering Deals and Alliances with Big Pharma and Partnering Deals and Alliances with Big Biotech

'Big pharma' or bigpharma is the collective name given to the top pharmaceutical companies in the world ranked by global sales of prescription drugs while big biotech or bigbiotech is the collective name given to the top biotechnology companies in the world ranked by global sales of prescription drugs.

View:

Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering deal talk

Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering deal talk.

Since 2007, there has been a consistent partnering activity by big pharma and big biotech companies as shown in the figures below:

Figure 1: Big pharma partnering 2007-2013

 

 

 

 

 

 

Source: Current Agreements, 2013

Figure 2: Big biotech partnering 2007-2013

 

 

 

 

 

 

Source: Current Agreements, 2013

Below is a list of the top big pharma and biotech players in dealmaking shown in two charts as recorded by Current Agreements database,

Figure 3: Most active big pharma partnering companies 2007-2013

 

 

 

 

 

 

 

 

Source: Current Agreements, 2013

Figure 4: Most active big biotech partnering companies 2007-2013

 

 

 

 

 

 

 

 

Source: Current Agreements, 2013

Another measure of partnering deal analysis activity apart from the number of deals signed/announced is the size of the deal. Deal size provides an indication of the significance of the deal and the potential opportunity for each party.

Figure 5: Leading big pharma partnering deals by value, 2007-2013

 

 

 

 

 

 

 

 

 

 

 

 

Source: Current Agreements, 2013

 Figure 6: Leading big biotech partnering deals by value, 2007-2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Source: Current Agreements, 2013

The therapeutic areas of focus for both big pharma and big biotech companies have been oncology followed by infectives, CNS and cardiovascular diseases.

The most active M&A dealmakers among the big pharma and biotech are

Figure 7: Most active Big Pharma M&A dealmakers 2007-2013

 

 

 

 

 

 

Source: Current Agreements, 2013

 Figure 8: Most active Big Biotech M&A dealmakers 2007-2013

 

 

 

 

 

Source: Current Agreements, 2013

The article is an abstract from the report: Partnering Deals and Alliances with Big Pharma and Partnering Deals and Alliances with Big Biotech

The Partnering Deals and Alliances with Big Pharma and Big Biotech reports provide the most comprehensive and in-depth insight into the dealmaking interests and activities of the world’s leading fifty big pharma and  biotech companies. It provides the reader with the tools necessary to make successful contact with the right big pharma/ biotech partners effectively and efficiently. The report includes detailed top 50 big pharma/ biotech company profiles, in-depth marketed and pipeline product activity of each company, partnering interests by deal type, phase of development, therapy and technology focus and most active of all big pharma and big biotech companies.. More details here

Sources

The above information has been abstracted from the following resources:

 

Related

Buy report: Partnering Deals and Alliances with Big Pharma and Big Biotech

Individual reports: Partnering Deals and Alliances with Big Pharma

Biotech Partnering Terms and Agreements

View: glossary definition for big pharma and big biotech

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new2gif
e80banner300x150animgif
a1banner300x150animgif